| Schedule of stock-based compensation expense |
| | |
Three Months Ended September 30, | | |
Nine Months Ended September 30, | |
| | |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| General and administrative: | |
| | |
| | |
| | |
| |
| RSU awards | |
$ | 23,928 | | |
$ | 114,527 | | |
$ | 108,040 | | |
$ | 323,095 | |
| Stock Options | |
| (10,912 | ) | |
| — | | |
| 36,784 | | |
| — | |
| General and administrative stock-based compensation expense | |
| 13,016 | | |
| 114,527 | | |
| 144,824 | | |
| 323,095 | |
| Research and development: | |
| | | |
| | | |
| | | |
| | |
| RSU awards | |
| 6,021 | | |
| 16,793 | | |
| 39,608 | | |
| 41,871 | |
| Stock Options | |
| 21,638 | | |
| — | | |
| 84,323 | | |
| — | |
| Research and development stock-based compensation expense | |
| 27,659 | | |
| 16,793 | | |
| 123,931 | | |
| 41,871 | |
| Total stock-based compensation expense | |
$ | 40,675 | | |
$ | 131,320 | | |
$ | 268,755 | | |
$ | 364,966 | |
|
| | |
Year Ended December 31, 2021 | | |
Year Ended December 31, 2020 | |
| General and administrative | |
$ | 412,214 | | |
| 27,446 | |
| Research and development | |
| 58,664 | | |
| 1,786 | |
| Total share-based compensation expense | |
$ | 470,878 | | |
| 29,232 | |
|
| Schedule of activity related to stock options |
| | |
Shares | | |
Weighted-average
Exercise Price | | |
Weighted-average
Remaining Contractual Term (Years) | |
| Outstanding
at December 31, 2021 | |
| — | | |
$ | — | | |
| | |
| Granted | |
| 550,273 | | |
| 1.10 | | |
| | |
| Exercised | |
| — | | |
| — | | |
| | |
| Expired
and foreited | |
| (197,960 | ) | |
| 1.40 | | |
| | |
| Outstanding
at September 30, 2022 | |
| 352,313 | | |
$ | 0.93 | | |
| 5.3 | |
| Exercisable
at September 30, 2022 | |
| 212,513 | | |
$ | 0.63 | | |
| 2.6 | |
|
|